Optimizing Treatment for Bone Metastases in Patients with Advanced Cancers

Understand current practice patterns related to bone metastases in patients with advanced cancers. Patient specific unfolding case scenarios presented to 174 high-prescribing oncologists on the treatment of bones metastases in patients with advanced stages of cancer including breast, renal cell carcinoma, and prostate. The survey was presented for their responses on clinical decisions. Oncologists were asked to respond to open-ended questions concerning their choices of treatment regimens, factors that influence their decisions, and barriers to optimal patient management. The survey was administered electronically by Qualtrics survey software between December 15, 2010 and March 31, 2011. Patient progression reveals decisions in treatment throughout patient stages.

Patient case highlights:

• ER/PR positive HER2/neu negative metastatic breast cancer with bone metastases
• Metastatic breast cancer with bone metastases in a patient with multiple comorbidities
• Metastatic clear cell carcinoma with lytic bone lesions
• Patient with increased PSA and adenocarcinoma
• Patient with asymptomatic castration-resistant metastatic disease
• Symptomatic prostate disease in an elderly patient with Gleason’s 5+5 and widespread metastatic disease

Treatment decisions for advanced stages of cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists’ choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer.

This report allows you to:

Understand what occurs in physician practice and why
See the variations in practice patterns
Understand where treatments fit in physician decisions
Gain actionable data for marketing strategies